Inversion opposition "a lot of noise," Mylan CEO says

Even before the expected early 2015 close of Mylan Inc.’s controversial pending purchase of Abbott Laboratories’ generic European businesses, the Southpointe-based pharmaceuticals firm could execute another deal...